Specialty Pharma Journal Specialty, Precision & Technology

INDIANAPOLIS, Jan. 18, 2019 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today reported that the results of ANNOUNCE, …

WOONSOCKET, R.I. and BENTONVILLE, Ark., Jan. 18, 2019 /PRNewswire/ — CVS Health (NYSE: CVS) and Walmart (NYSE: WMT) today …

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Obsidian Therapeutics, a biotechnology company developing cell therapies with pharmacologic operating systems, today …

MORRIS PLAINS, N.J., Jan. 17, 2019 (GLOBE NEWSWIRE) — Immunomedics, Inc., (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a …

ARDSLEY, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that The Lancet Neurologypublished results from SPAN℠-PD, the Phase …

PARIS–(BUSINESS WIRE)–Servier and Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), …

PARIS and THE WOODLANDS, TX – January 17, 2019 – The Endocrinologic and Metabolic Drugs Advisory …

WALTHAM, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that …

HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI) announced today that it has entered into a …

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …

THOUSAND OAKS, Calif. and BRUSSELS, Jan. 16, 2019 /PRNewswire/ — Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced strong support …

SOUTH SAN FRANCISCO, Calif., Jan. 16, 2019 /PRNewswire/ — Actelion Pharmaceuticals Ltd, one of the …

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 …

ABBOTT PARK, Ill., Jan. 16, 2019 /PRNewswire/ — Abbott (NYSE: ABT) announced today that it has exercised its option …

BOSTON–(BUSINESS WIRE)–ZappRx, a digital health company that streamlines the complex processes associated with prescribing specialty …